Amicus reports positive results from four phase II clinical trials of Amigal for Fabry disease Dec. 27, 2007
FDA grants orphan drug status to Anthera's A-001 for acute chest syndrome in sickle cell disease Dec. 27, 2007
Ambrx enters collaboration with Merck & Co. to develop FGF-21 follow-up type 2 diabetes drug Dec. 27, 2007